Suppr超能文献

用于与血液接触应用的基于聚氨酯的微流控装置。

Polyurethane-based microfluidic devices for blood contacting applications.

机构信息

Department of Mechanical Engineering, McMaster University, Hamilton, ON, Canada.

出版信息

Lab Chip. 2012 Mar 7;12(5):960-70. doi: 10.1039/c2lc21075d. Epub 2012 Jan 25.

Abstract

Protein adsorption on PDMS surfaces poses a significant challenge in microfluidic devices that come into contact with biofluids such as blood. Polyurethane (PU) is often used for the construction of medical devices, but despite having several attractive properties for biointerfacing, it has not been widely used in microfluidic devices. In this work we developed two new fabrication processes for making thin, transparent and flexible PU-based microfluidic devices. Methods for the fabrication and bonding of microchannels, the integration of fluidic interconnections and surface modification with hydrophilic polyethylene oxide (PEO) to reduce protein adsorption are detailed. Using these processes, microchannels were produced having high transparency (96% that of glass in visible light), high bond strength (326.4 kPa) and low protein adsorption (80% reduction in fibrinogen adsorption vs. unmodified PDMS), which is critical for prevention of fouling. Our findings indicate that PEO modified PU could serve as an effective alternative to PDMS in blood contacting microfluidic applications.

摘要

蛋白质在与血液等生物流体接触的 PDMS 表面上的吸附,对微流控设备构成了重大挑战。聚氨酯(PU)常用于医疗器械的构建,但尽管它具有生物界面的几个吸引人的特性,但在微流控设备中尚未得到广泛应用。在这项工作中,我们开发了两种新的制造工艺,用于制造薄的、透明的和灵活的基于 PU 的微流控器件。详细介绍了制造和键合微通道的方法、流体连接的集成以及表面改性与亲水性聚乙烯氧化物(PEO)以减少蛋白质吸附。使用这些工艺,制造出的微通道具有高透明度(可见光下 96%的玻璃透光率)、高强度键合(326.4 kPa)和低蛋白质吸附(与未改性 PDMS 相比,纤维蛋白原吸附减少 80%),这对于防止堵塞至关重要。我们的研究结果表明,PEO 改性的 PU 可以作为接触血液的微流控应用中 PDMS 的有效替代品。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验